HPR95 Public-Private Partnership Model in Oncology: Business Opportunities for Next Generation Contract Research Organizations in the Context of CancerXKapil Khambholja, V Chhaya|Value in Health|2023Cited by 1
MSR14 Unleashing the Potential of Artificial Intelligence in Genomic Biomarker Testing for Precision Oncology: A Scoping ReviewFriederike Buch, Kapil Khambholja, V Chhaya et al.|Value in Health|2023Cited by 0
SA60 Key Challenges in Gene Therapy Development for Usher Syndrome: Insights from Machine-Assisted Rapid Scoping ReviewRajeev Bhat, Kapil Khambholja, Brahmajee K. Nallamothu et al.|Value in Health|2023Cited by 0
HPR148 Adopting CeSHarP M11 Guidelines for Oncology Protocol Digitalization: Findings and Action RecommendationsSaba Bajwa, Kapil Khambholja, V Chhaya et al.|Value in Health|2024Cited by 0
HPR48 Relationship Between Genetic Heterogeneity and Acquired Resistance to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Targeted Literature ReviewV Chhaya, Kapil Khambholja|Value in Health|2024Cited by 0